Previous 10 | Next 10 |
WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at the 2019 Cantor Global Healthcare Conference as follows: The presentati...
The following slide deck was published by Rockwell Medical, Inc. in conjunction with this Read more ...
WIXOM, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chroni...
The first duty of a man is to think for himself " - Jose Marti Today, we look at a small biopharma company whose stock has seen better days. However, the firm has new management and could be a possible turnaround play in the market and has also seen some recent insider buying in its share...
WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at two upcoming conferences as follows: The presentations will be webcast l...
Rockwell Medical, Inc. (RMTI) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Ilanit Allen – Investor Relations Stuart Paul – President and Chief Executive Officer Angus Smith – Chief Financial Officer Conference Call Partici...
Rockwell Medical (NASDAQ: RMTI ): Q2 GAAP EPS of -$0.18 misses by $0.02 . Revenue of $14.8M (-0.7% Y/Y) misses by $1.69M . Press Release More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news, ,
– Company Records First Commercial Sales of Dialysate Triferic®; FDA Accepts New Drug Application for I.V. Triferic with PDUFA date of March 28, 2020 – WIXOM, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical”...
– Positive data suggests no ethnic difference in Triferic PK in Chinese subjects compared to U.S. subjects – – China studies indicate similar delivery of iron via dialysate as in U.S. studies – WIXOM, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical,...
WIXOM, Mich., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney diseas...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...